Literature DB >> 12866532

How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains.

J Fantini1.   

Abstract

Understanding the molecular mechanisms controlling the association of proteins with lipid rafts is a central issue in cell biology and medicine. A structurally conserved motif (the 'sphingolipid binding domain') has been characterized in unrelated cellular and microbial proteins targeted to lipid rafts. I propose that the structuration of a sphingolipid shell around the sphingolipid binding domain not only extracts the protein from the liquid-disordered phase of the plasma membrane, and ensures its delivery to lipid rafts, but also influences its conformation. The chaperone activity of sphingolipids in shells and rafts may play an important role in infectious and conformational diseases(human immunodeficiency virus-1, prions, Alzheimer).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12866532     DOI: 10.1007/s00018-003-3003-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  17 in total

1.  Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β.

Authors:  Ali Reza A Ladiwala; Mauricio Mora-Pale; Jason C Lin; Shyam Sundhar Bale; Zachary S Fishman; Jonathan S Dordick; Peter M Tessier
Journal:  Chembiochem       Date:  2011-06-10       Impact factor: 3.164

2.  Identification and in silico analysis of helical lipid binding regions in proteins belonging to the amphitropic protein family.

Authors:  Rob C A Keller
Journal:  J Biosci       Date:  2014-12       Impact factor: 1.826

Review 3.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

4.  Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation.

Authors:  Adrien W Schmid; Enrico Condemi; Gabriele Tuchscherer; Diego Chiappe; Manfred Mutter; Horst Vogel; Marc Moniatte; Yury O Tsybin
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

5.  Metabolic Depletion of Sphingolipids Does Not Alter Cell Cycle Progression in Chinese Hamster Ovary Cells.

Authors:  Bhagyashree D Rao; Parijat Sarkar; Amitabha Chattopadhyay
Journal:  J Membr Biol       Date:  2021-08-14       Impact factor: 1.843

6.  Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry.

Authors:  Himanshu Garg; Nicholas Francella; Kurissery A Tony; Line A Augustine; Joseph J Barchi; Jacques Fantini; Anu Puri; David R Mootoo; Robert Blumenthal
Journal:  Antiviral Res       Date:  2008-05-19       Impact factor: 5.970

7.  Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide.

Authors:  Coralie Di Scala; Nouara Yahi; Clément Lelièvre; Nicolas Garmy; Henri Chahinian; Jacques Fantini
Journal:  ACS Chem Neurosci       Date:  2012-12-27       Impact factor: 4.418

8.  Evidence for coupled biogenesis of yeast Gap1 permease and sphingolipids: essential role in transport activity and normal control by ubiquitination.

Authors:  Elsa Lauwers; Guido Grossmann; Bruno André
Journal:  Mol Biol Cell       Date:  2007-06-06       Impact factor: 4.138

Review 9.  Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases.

Authors:  Jacques Fantini; Nouara Yahi
Journal:  Expert Rev Mol Med       Date:  2010-09-01       Impact factor: 5.600

10.  Weak glycolipid binding of a microdomain-tracer peptide correlates with aggregation and slow diffusion on cell membranes.

Authors:  Tim Lauterbach; Manoj Manna; Maria Ruhnow; Yudi Wisantoso; Yaofeng Wang; Artur Matysik; Kamila Oglęcka; Yuguang Mu; Susana Geifman-Shochat; Thorsten Wohland; Rachel Kraut
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.